⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
TAK News
Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)
THE SKIN OF COLOR SOCIETY (SOCS) SUCCESSFULLY PRESENTS LANDMARK SYMPOSIUM CHAMPIONING EVIDENCE-BASED DERMATOLOGY AND COLLABORATION
prnewswire.com
ABBV
JNJ
ARQT
BMY
LLY
INCY
SNY
REGN
PFE
UCB
BIIB
ORGN
TAK
ELMD
Immuno-Oncology Drugs Market Opportunity Analysis and Forecast Report 2026-2035: Merck & Co. Remains a Dominant Force, Supported by the Commercial Success of Keytruda
globenewswire.com
MRK
BMY
GILD
TAK
ISPE Announces 2026 Facility of the Year Awards (FOYA) Category Winners
prnewswire.com
AMGN
SNY
LLY
AZN
TAK
World Hemophilia Day 2026 - April 17, 2026 - "Diagnosis: First step to care." USA - English India - English
prnewswire.com
BMRN
CSL
GRFS
NVO
PFE
REGN
SAN
TAK
Adimab Collaborator GSK Receives Additional Marketing Approval for Depemokimab
prnewswire.com
GSK
BIIB
LLY
MRK
TAK
ALNY
BMY
NVS
REGN
VRTX
Tim Foley Joins Deep Origin as Chief Commercial Officer
globenewswire.com
TAK
ALM
Takeda’s Zasocitinib Delivered Rapid and Durable Skin Clearance in a Convenient Once-Daily Pill, Affirming Promise to Reshape Psoriasis Care
businesswire.com
TAK
1日1回投与の利便性を備えた経口薬であるザソシチニブによる、迅速かつ持続的な皮膚症状の改善効果および乾癬治療を変革する可能性を示唆した臨床試験結果の発表について
businesswire.com
TAK
1日1回投与の利便性を備えた経口薬であるザソシチニブによる、迅速かつ持続的な皮膚症状の改善効果および乾癬治療を変革する可能性を示唆した臨床試験結果の発表について
businesswire.com
TAK
Plasma Fractionation Market to Reach USD 51.06 Billion by 2032, Driven by Rising Demand for Immunoglobulins and Growing Prevalence of Immune Disorders | MarkNtel Advisors
prnewswire.com
CSL
TAK